These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31627256)

  • 1. A missense mutation in the catalytic domain of O-GlcNAc transferase links perturbations in protein O-GlcNAcylation to X-linked intellectual disability.
    Pravata VM; Gundogdu M; Bartual SG; Ferenbach AT; Stavridis M; Õunap K; Pajusalu S; Žordania R; Wojcik MH; van Aalten DMF
    FEBS Lett; 2020 Feb; 594(4):717-727. PubMed ID: 31627256
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Selvan N; George S; Serajee FJ; Shaw M; Hobson L; Kalscheuer V; Prasad N; Levy SE; Taylor J; Aftimos S; Schwartz CE; Huq AM; Gecz J; Wells L
    J Biol Chem; 2018 Jul; 293(27):10810-10824. PubMed ID: 29769320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in
    Willems AP; Gundogdu M; Kempers MJE; Giltay JC; Pfundt R; Elferink M; Loza BF; Fuijkschot J; Ferenbach AT; van Gassen KLI; van Aalten DMF; Lefeber DJ
    J Biol Chem; 2017 Jul; 292(30):12621-12631. PubMed ID: 28584052
    [No Abstract]   [Full Text] [Related]  

  • 4. Catalytic deficiency of O-GlcNAc transferase leads to X-linked intellectual disability.
    Pravata VM; Muha V; Gundogdu M; Ferenbach AT; Kakade PS; Vandadi V; Wilmes AC; Borodkin VS; Joss S; Stavridis MP; van Aalten DMF
    Proc Natl Acad Sci U S A; 2019 Jul; 116(30):14961-14970. PubMed ID: 31296563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An O-GlcNAc transferase pathogenic variant linked to intellectual disability affects pluripotent stem cell self-renewal.
    Omelková M; Fenger CD; Murray M; Hammer TB; Pravata VM; Bartual SG; Czajewski I; Bayat A; Ferenbach AT; Stavridis MP; van Aalten DMF
    Dis Model Mech; 2023 Jun; 16(6):. PubMed ID: 37334838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a missense mutation in the
    Vaidyanathan K; Niranjan T; Selvan N; Teo CF; May M; Patel S; Weatherly B; Skinner C; Opitz J; Carey J; Viskochil D; Gecz J; Shaw M; Peng Y; Alexov E; Wang T; Schwartz C; Wells L
    J Biol Chem; 2017 May; 292(21):8948-8963. PubMed ID: 28302723
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurodevelopmental defects in a mouse model of O-GlcNAc transferase intellectual disability.
    Authier F; Ondruskova N; Ferenbach AT; McNeilly AD; van Aalten DMF
    Dis Model Mech; 2024 Apr; 17(4):. PubMed ID: 38566589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The O-GlcNAc Transferase Intellectual Disability Mutation L254F Distorts the TPR Helix.
    Gundogdu M; Llabrés S; Gorelik A; Ferenbach AT; Zachariae U; van Aalten DMF
    Cell Chem Biol; 2018 May; 25(5):513-518.e4. PubMed ID: 29606577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatic prediction of putative conveyers of O-GlcNAc transferase intellectual disability.
    Mitchell CW; Czajewski I; van Aalten DMF
    J Biol Chem; 2022 Sep; 298(9):102276. PubMed ID: 35863433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intellectual disability syndrome with single-nucleotide variants in O-GlcNAc transferase.
    Pravata VM; Omelková M; Stavridis MP; Desbiens CM; Stephen HM; Lefeber DJ; Gecz J; Gundogdu M; Õunap K; Joss S; Schwartz CE; Wells L; van Aalten DMF
    Eur J Hum Genet; 2020 Jun; 28(6):706-714. PubMed ID: 32080367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intellectual disability-associated disruption of O-GlcNAc cycling impairs habituation learning in Drosophila.
    Fenckova M; Muha V; Mariappa D; Catinozzi M; Czajewski I; Blok LER; Ferenbach AT; Storkebaum E; Schenck A; van Aalten DMF
    PLoS Genet; 2022 May; 18(5):e1010159. PubMed ID: 35500025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an Interactome for the Tetratricopeptide Repeat Domain of O-GlcNAc Transferase Indicates a Role for the Enzyme in Intellectual Disability.
    Stephen HM; Praissman JL; Wells L
    J Proteome Res; 2021 Feb; 20(2):1229-1242. PubMed ID: 33356293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroectoderm phenotypes in a human stem cell model of O-GlcNAc transferase associated with intellectual disability.
    Murray M; Davidson L; Ferenbach AT; Lefeber D; van Aalten DMF
    Mol Genet Metab; 2024 Jun; 142(2):108492. PubMed ID: 38759397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The O-GlcNAc cycling in neurodevelopment and associated diseases.
    Wenzel DM; Olivier-Van Stichelen S
    Biochem Soc Trans; 2022 Dec; 50(6):1693-1702. PubMed ID: 36383066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The active site of O-GlcNAc transferase imposes constraints on substrate sequence.
    Pathak S; Alonso J; Schimpl M; Rafie K; Blair DE; Borodkin VS; Albarbarawi O; van Aalten DMF
    Nat Struct Mol Biol; 2015 Sep; 22(9):744-750. PubMed ID: 26237509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The non-catalytic domains of O-GlcNAc cycling enzymes present new opportunities for function-specific control.
    Hu CW; Wang K; Jiang J
    Curr Opin Chem Biol; 2024 Aug; 81():102476. PubMed ID: 38861851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAc transferase congenital disorder of glycosylation (OGT-CDG): Potential mechanistic targets revealed by evaluating the OGT interactome.
    Mayfield JM; Hitefield NL; Czajewski I; Vanhye L; Holden L; Morava E; van Aalten DMF; Wells L
    J Biol Chem; 2024 Sep; 300(9):107599. PubMed ID: 39059494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of recombinant human and Yarrowia lipolytica O-GlcNAc transferases expressed in Saccharomyces cerevisiae.
    Oh HJ; Moon HY; Cheon SA; Hahn Y; Kang HA
    J Microbiol; 2016 Oct; 54(10):667-74. PubMed ID: 27687229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
    Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
    Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.